33 related articles for article (PubMed ID: 8836521)
1. Structure activity relationship study of benzo[d]thiazol-2(3H)one based σ receptor ligands.
Bhat R; Fishback JA; Matsumoto RR; Poupaert JH; McCurdy CR
Bioorg Med Chem Lett; 2013 Sep; 23(17):5011-3. PubMed ID: 23867168
[TBL] [Abstract][Full Text] [Related]
2. Juxtaposition of the steroid binding domain-like I and II regions constitutes a ligand binding site in the sigma-1 receptor.
Pal A; Chu UB; Ramachandran S; Grawoig D; Guo LW; Hajipour AR; Ruoho AE
J Biol Chem; 2008 Jul; 283(28):19646-56. PubMed ID: 18467334
[TBL] [Abstract][Full Text] [Related]
3. Sigma Receptor Ligands Are Potent Antiprion Compounds that Act Independently of Sigma Receptor Binding.
Mercer RCC; Le NTT; Fraser DG; Houser MCQ; Beeler AB; Harris DA
ACS Chem Neurosci; 2024 Jun; 15(11):2265-2282. PubMed ID: 38743607
[TBL] [Abstract][Full Text] [Related]
4. Sigma receptor ligands are potent anti-prion compounds that act independently of sigma receptor binding.
Mercer RCC; Le NTT; Houser MCQ; Beeler AB; Harris DA
bioRxiv; 2023 Nov; ():. PubMed ID: 38077011
[TBL] [Abstract][Full Text] [Related]
5. Sequence analysis, structure and binding site prediction of Sigma 1 receptor protein by in silico method.
Latha NL; Gyananath G; Zubaidha PK
Bioinformation; 2013; 9(19):944-51. PubMed ID: 24391355
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
[TBL] [Abstract][Full Text] [Related]
7. Review of the pharmacological and clinical profile of rimcazole.
Gilmore DL; Liu Y; Matsumoto RR
CNS Drug Rev; 2004; 10(1):1-22. PubMed ID: 14978511
[TBL] [Abstract][Full Text] [Related]
8. Sigma binding sites in the brain; an emerging concept for multiple sites and their relevance for psychiatric disorders.
Itzhak Y; Stein I
Life Sci; 1990; 47(13):1073-81. PubMed ID: 2172677
[TBL] [Abstract][Full Text] [Related]
9. 1-Cyclohexylpiperazine and 3,3-dimethylpiperidine derivatives as sigma-1 (sigma1) and sigma-2 (sigma2) receptor ligands: a review.
Berardi F; Abate C; Ferorelli S; Colabufo NA; Perrone R
Cent Nerv Syst Agents Med Chem; 2009 Sep; 9(3):205-19. PubMed ID: 20021355
[TBL] [Abstract][Full Text] [Related]
10. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
Brent PJ
Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
[TBL] [Abstract][Full Text] [Related]
11. Haloperidol and reduced haloperidol-induced exacerbation of the dystonia produced by the kappa opioid U50,488H in guinea-pigs is associated with inhibition of sigma binding sites: behavioural and autoradiographical studies.
Brent PJ
Brain Res; 1995 Jul; 684(2):115-26. PubMed ID: 7583212
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligands.
de Costa BR; Bowen WD; Hellewell SB; George C; Rothman RB; Reid AA; Walker JM; Jacobson AE; Rice KC
J Med Chem; 1989 Aug; 32(8):1996-2002. PubMed ID: 2547074
[TBL] [Abstract][Full Text] [Related]
13. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
Brent PJ
Neuropharmacology; 1993 Aug; 32(8):751-60. PubMed ID: 8413839
[TBL] [Abstract][Full Text] [Related]
14. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
15. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
